coated with PGT (poly L-glutamic acid L-tyrosine, 4:1, Sigma Aldrich, MO, USA)
and incubated at 37°C for 48h prior to using. PGT served as the substrate
to be phosphorylated by EGFR (Enzo Life Sciences Inc, NY, USA, Signal Chem,
Richmond, Canada) and c-Src (Enzo Life Sciences Inc, NY, USA, Signal Chem,
Richmond, Canada) in the presence of ATP (50 μM). A dose range of drugs
(
to bind and inhibit the ATP-binding site in the kinase domain of EGFR or c-Src.
To each well, 15 ng of EGFR (20 μg/ml) or 6 ng of c-Src (0.1
μg/μl) were added. The phosphorylated substrate was detected using
an HRP-conjugated anti-phosphotyrosine antibody (Santa Cruz Biotechnology, CA).
The signal was developed by the addition of 3, 3’, 5,
5’-tetramethylbenzidine peroxidase substrate (Kierkegaard and Perry
Laboratories, Gaithersburg, MD) and the colorimetric reaction was monitored at
450 nm using a microplate reader ELx808 (BioTek Instruments). The
IC50 values were calculated using GraphPad Prism 6.0
(GraphPadSoftware, Inc., San Diego, CA). Each experiment was carried out at
least three times, in duplicate.